There are currently no drugs that stop or inhibit Alzheimer’s disease. Despite drug trials showing plaque reduction in the brain, the patients’ cognitive function did not improve. Would the results be different if it were possible to design studies that intervene much earlier on in the disease, before cognition is affected? This is what an international study has attempted to facilitate.